DT&CRO Co (383930.KQ) Hisse Fiyat

DT&CRO Co Ltd is a South Korean company operating in the Health Care sector, specifically within the Life Sciences Tools & Services industry. Based in Yongin, the company has 277 employees and completed its initial public offering (IPO) on November 11, 2022. DT&CRO Co Ltd provides non-clinical and clinical trial services for pharmaceuticals, medical devices, food, chemicals, and cosmetics. The company also offers analysis, efficacy evaluation, and related services. Its headquarters are located in Yongin, Gyeonggi-Do, South Korea. The company's website is www.dtncro.com. DT&CRO Co Ltd is engaged in research and development activities related to medicine and pharmaceuticals, though specific details about its R&D focus or product offerings are not provided in the available information. The company operates as a service provider in the life sciences sector, supporting various industries through trial services and analytical solutions. As a publicly traded company, it is listed under the ticker symbol 383930.KQ with ISIN KR7383930005. The company's operations are centered on delivering specialized services to clients in the pharmaceutical and related industries, emphasizing both non-clinical and clinical trial support.